2 results
Approved WMOPending
The main goal of this study is to evaluate the effectiveness of the NESS L300 on walking skills, as compared to a conventional ankle-foot orthosis, in stroke patients with a drop foot.
Approved WMORecruiting
PRIMARY: Dose finding part (Phase 1):To assess the safety and tolerability of durvalumab when given in combination with lenalidomide and rituximab; ibrutinib; or bendamustine and rituximab to determine the recommended Phase 2 doses (RP2Ds) of each…